Report #2835703

Received Apr 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: CO
Recovered: Not recovered
Vaccinated: Jan 15, 2025
Onset: Feb 18, 2025
Days to onset: 34
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	—	—

Symptoms (1)

Upper respiratory tract infection

Symptom narrative

Upper Respiratory Infection; This spontaneous report was received from a physician assistant via company representative regarding to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-JAN-2025, the patient was vaccinated with pneumococcal 21-valent conjugate vaccine (CAPVAXIVE) via intramuscular, (strength, dose, frequency, anatomical injection site, lot number and expiration date were not reported), for the treatment of immunization/prevention of pneumonia caused by strep pneumoniae. On 18-FEB-2025, the patient experienced upper respiratory infection. At the reporting time, the patient had not recovered from the event. The reporter considered the event to be related to pneumococcal 21-valent conjugate vaccine (CAPVAXIVE). Lot # is being requested and will be submitted if received.